At American Gene Technologies we are very proud and fortunate to work with some of the best scientific and clinical advisors in their fields. As a team we continually push our research forward.
Our experienced executive team is committed to finding innovative solutions for patients living with infectious diseases, cancer, and monogenic disorders.
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies.
C. David Pauza, PhD
David has 35 years of experience in human viral diseases, immunology and cancer biology with more than 200 publications. Prior to joining AGT he held faculty positions at the University of Wisconsin School of Medicine and University of Maryland Medical School where he is now Adjunct Professor of Medicine.
C. Neil Lyons, CPA
Chief Financial Officer &
Executive Vice President
Neil has more than 30 years of experience in finance, strategy, raising capital, SEC compliance, and corporate governance in both public and private companies, with over 10 years of that leading finance for publicly-traded, clinical-stage biotechnology companies.
BOARD OF DIRECTORS
CEO and Founder
Jeff earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of…
Jason T. Thompson
Jason combines legal experience and strategic vision in helping his clients structure, negotiate, and integrate corporate acquisitions. His training as a certified public accountant adds...
Aaron Galvin earned his BS and MS from the Massachusetts Institute of Technology (MIT), joining the MIT Lincoln Labs to pioneer innovations to radar as well as developing technologies for various classified…
Qi Tang has developed manufacturing and import/export businesses throughout China and the United States, and has invested several times throughout AGT’s growth.
Julia Brown has served on the board of directors of nine drug development companies with a focus on governance and compensation. She currently serves on the board and as a member of the…
Senior Advisor to the CEO
Tommy Thompson, former Secretary of the United States Department of Health and Human Services, worked fervently to modernize healthcare delivery as the former Governor of…
Dr. Robert R. Redfield
Special Advisor to the CEO
Dr. Redfield is well known for his decades of dedicated work in virology, immunology and clinical research. He has helped lead collaborative research into HIV/AIDS since the beginning of the epidemic...
Snell & Wilmer strategically develops our intellectual property.
Foley & Lardner protects our innovative technologies and cures.
Cooley, LLP provides AGT with corporate legal advice.
Ernst & Young serves as our independent public accountant.